InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Johnson Kevin C, Director. Director active across 1 company, notably Neogenomics INC. In total, 2 filings have been published. History available since 2 June 2021. The latest transaction was filed on 22 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Johnson Kevin C is a Board Member at NEOGENOMICS INC. He contributes to the governance of the company by providing strategic advice and overseeing development initiatives.